{"id":"https://openalex.org/W7216626839","doi":null,"title":"Multiple-targeting ligands for AKR1C3 enzyme and androgen receptor to target prostate cancer","display_name":"Multiple-targeting ligands for AKR1C3 enzyme and androgen receptor to target prostate cancer","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W7216626839"},"language":"en","primary_location":{"id":"pmh:oai:iris.unito.it:2318/1852081","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2318/1852081","pdf_url":null,"source":{"id":"https://openalex.org/S4306400637","display_name":"Institutional Research Information System University of Turin (University of Turin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I55143463","host_organization_name":"University of Turin","host_organization_lineage":["https://openalex.org/I55143463"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/conferencePoster"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080055756","display_name":"Agnese Chiara Pippione","orcid":"https://orcid.org/0000-0003-3778-8420","observed_orcids":["https://orcid.org/0000-0003-3778-8420"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Agnese Chiara Pippione","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103259332","display_name":"Z\u00fchal K\u0131l\u0131\u00e7-Kurt","orcid":"https://orcid.org/0000-0002-7491-4089","observed_orcids":["https://orcid.org/0000-0002-7491-4089"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zuhal Kilic-Kurt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012424953","display_name":"Stefano Sainas","orcid":"https://orcid.org/0000-0001-5010-8536","observed_orcids":["https://orcid.org/0000-0001-5010-8536"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefano Sainas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092760426","display_name":"Iole Mannella","orcid":"https://orcid.org/0009-0000-6354-6535","observed_orcids":["https://orcid.org/0009-0000-6354-6535"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Iole Mannella","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047107350","display_name":"Barbara Rolando","orcid":"https://orcid.org/0000-0001-6138-1503","observed_orcids":["https://orcid.org/0000-0001-6138-1503"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barbara Rolando","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054079349","display_name":"Sandra Kovachka","orcid":"https://orcid.org/0000-0003-4488-7427","observed_orcids":["https://orcid.org/0000-0003-4488-7427"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandra Kovachka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053183150","display_name":"Francesca Spyrakis","orcid":"https://orcid.org/0000-0002-4016-227X","observed_orcids":["https://orcid.org/0000-0002-4016-227X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesca Spyrakis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087404951","display_name":"Annamaria Buschini","orcid":"https://orcid.org/0000-0002-9877-2767","observed_orcids":["https://orcid.org/0000-0002-9877-2767"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annamaria Buschini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046310331","display_name":"Serena Montalbano","orcid":"https://orcid.org/0000-0002-2316-7159","observed_orcids":["https://orcid.org/0000-0002-2316-7159"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Serena Montalbano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032908007","display_name":"Simonetta Oliaro Bosso","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simonetta Oliaro Bosso","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5155012805","display_name":"Lolli Marco Lucio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marco Lolli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5062037258","display_name":"Donatella Boschi","orcid":"https://orcid.org/0000-0003-4929-4460","observed_orcids":["https://orcid.org/0000-0003-4929-4460"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Donatella Boschi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12533","display_name":"Aldose Reductase and Taurine","score":0.40380001068115234,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12533","display_name":"Aldose Reductase and Taurine","score":0.40380001068115234,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.2705000042915344,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.19820000231266022,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/akr1c3","display_name":"AKR1C3","score":0.9049999713897705},{"id":"https://openalex.org/keywords/androgen-receptor","display_name":"androgen receptor","score":0.8899999856948853},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.8859999775886536},{"id":"https://openalex.org/keywords/akr1c3-inhibitors","display_name":"AKR1C3 inhibitors","score":0.8679999709129333},{"id":"https://openalex.org/keywords/androgen-biosynthesis","display_name":"androgen production","score":0.7730000019073486},{"id":"https://openalex.org/keywords/dihydrotestosterone","display_name":"dihydrotestosterone","score":0.6340000033378601},{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":0.8019999861717224},{"id":"https://openalex.org/keywords/darolutamide","display_name":"darolutamide","score":0.9399999976158142},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.6209999918937683},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.5950000286102295}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7754999995231628},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.703499972820282},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.6992999911308289},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.651199996471405},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.6223000288009644},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.6128000020980835},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.49630001187324524},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44929999113082886},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.43369999527931213},{"id":"https://openalex.org/C2910322876","wikidata":"https://www.wikidata.org/wiki/Q574820","display_name":"Androgen Receptor Antagonists","level":5,"score":0.42250001430511475},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.376800000667572},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36809998750686646},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.35280001163482666},{"id":"https://openalex.org/C2777911890","wikidata":"https://www.wikidata.org/wiki/Q62614","display_name":"Androgen","level":3,"score":0.3359000086784363},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.33480000495910645},{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.3127000033855438},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.295199990272522},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.288100004196167},{"id":"https://openalex.org/C2779881493","wikidata":"https://www.wikidata.org/wiki/Q411054","display_name":"Dihydrotestosterone","level":4,"score":0.2806999981403351},{"id":"https://openalex.org/C2779396153","wikidata":"https://www.wikidata.org/wiki/Q901227","display_name":"Natural product","level":2,"score":0.27630001306533813},{"id":"https://openalex.org/C2992339755","wikidata":"https://www.wikidata.org/wiki/Q3817769","display_name":"Transcriptional activity","level":4,"score":0.2734000086784363},{"id":"https://openalex.org/C553450214","wikidata":"https://www.wikidata.org/wiki/Q851162","display_name":"Biosynthesis","level":3,"score":0.2685999870300293},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.2651999890804291},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.263700008392334},{"id":"https://openalex.org/C2779723316","wikidata":"https://www.wikidata.org/wiki/Q6459234","display_name":"LNCaP","level":4,"score":0.26170000433921814},{"id":"https://openalex.org/C2779322244","wikidata":"https://www.wikidata.org/wiki/Q574820","display_name":"Antiandrogen","level":4,"score":0.26080000400543213},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2581000030040741},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.25369998812675476},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.25360000133514404}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:iris.unito.it:2318/1852081","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2318/1852081","pdf_url":null,"source":{"id":"https://openalex.org/S4306400637","display_name":"Institutional Research Information System University of Turin (University of Turin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I55143463","host_organization_name":"University of Turin","host_organization_lineage":["https://openalex.org/I55143463"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/conferencePoster"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8307999968528748,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2075145938","https://openalex.org/W2909189323","https://openalex.org/W4224024426","https://openalex.org/W7217066312","https://openalex.org/W7077171338","https://openalex.org/W2039169182","https://openalex.org/W3080468866","https://openalex.org/W3009146602","https://openalex.org/W7217080686","https://openalex.org/W2808349648"],"abstract_inverted_index":{"The":[0,49,151],"enzyme":[1,176],"aldo-keto":[2],"reductase":[3],"1C3":[4],"(AKR1C3)":[5],"is":[6],"considered":[7],"an":[8],"attractive":[9],"target":[10],"in":[11,20,46,54],"Castration":[12],"Resistant":[13],"Prostate":[14],"Cancer":[15],"(CRPC)":[16],"for":[17,95,111,124,144],"its":[18],"role":[19],"the":[21,29,97,100],"biosynthesis":[22],"of":[23,56,156,177],"androgens":[24],"(testosterone":[25],"and":[26,39,70,99,103,114,128,153,171],"DHT).1":[27],"At":[28],"same":[30],"time,":[31],"antagonists":[32],"to":[33,64,86,134,149,185],"Androgen":[34],"Receptor":[35],"(AR)":[36],"as":[37,43,59,68,180,182],"enzalutamide":[38],"darolutamide":[40],"are":[41,52,61,159,188],"used":[42,85],"anticancer":[44],"drugs":[45],"CRPC":[47,164],"patients.":[48],"two":[50],"targets":[51],"compatible":[53],"terms":[55],"ligand":[57,146],"accommodation":[58],"they":[60],"both":[62,96,112],"able":[63,133],"interact":[65],"with":[66],"DHT":[67],"product":[69],"ligand,":[71],"respectively.":[72],"Our":[73],"group":[74],"already":[75],"discovered":[76],"new":[77,93,157,178],"potent":[78],"AKR1C3":[79,113,131,175],"inhibitors,":[80],"where":[81],"hydroxylated":[82],"heterocycles":[83],"were":[84],"mimic":[87],"acidic":[88],"functions.1,2":[89],"We":[90],"here":[91,189],"propose":[92],"derivatives":[94],"hydroxybenzoisoxazole":[98],"hydroxytriazole":[101],"series,":[102],"move":[104],"our":[105],"attention":[106],"on":[107,126,174],"obtaining":[108],"multiple":[109],"ligands":[110],"AR.":[115],"To":[116],"do":[117],"this,":[118],"we":[119],"identified":[120],"structural":[121],"elements":[122],"required":[123],"activity":[125,173],"AR":[127,136],"found":[129],"some":[130],"inhibitors":[132],"play":[135],"antagonism":[137],"activity;":[138],"this":[139],"represent":[140],"a":[141],"starting":[142],"point":[143],"multiple-targeting":[145],"development":[147],"applied":[148],"CRPC.":[150],"potency":[152],"dual":[154],"action":[155],"compounds":[158],"translated":[160],"into":[161],"citotoxicity":[162],"against":[163],"cellular":[165],"models.":[166],"In":[167],"silico":[168],"design,":[169],"synthesis":[170],"biological":[172],"compounds,":[179],"well":[181],"their":[183],"capability":[184],"address":[186],"AR,":[187],"described.":[190]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-03T00:00:00"}